LT - Natrio (2R,5S,13aR) -7,9-diokso-10-((2,4,6-trifluorbenzil) karbamoil) -2,3,4,5,7,9,13,13A-oktahidro-2,5-metanopirido [1',2' : 4,5]pirazino[2,1-b]oksazepin-8-olatas
EN - SODIUM (2R, 5S, 13AR) -7, 9-DIOXO-10- ( (2,4,6-TRIFLUOROBENZYL) CARBAMOYL) -2, 3, 4, 5, 7, 9, 13, 13A-OCTAHYDRO-2, 5-METHANOPYRIDO [1`,2` : 4.5]PYRAZINO [2, 1-B]OXAZEPIN-8-OLATE
Legal status
Patent revoked (after opposition at EPO)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 498/14 |
(2006.01) |
|
|
C07D 498/18 |
(2006.01) |
|
|
A61K 31/535 |
(2006.01) |
|
|
A61P 31/18 |
(2006.01) |
|
|
A61K 31/513 |
(2006.01) |
|
|
A61K 31/675 |
(2006.01) |
|
|
A61K 31/553 |
(2006.01) |
European patent
| (11) |
Number of the document |
3157932 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
15739063.4 |
|
Date of filing the European patent application |
2015-06-19 |
| (97) |
Date of publication of the European application |
2017-04-26 |
| (45) |
Date of publication and mention of the grant of the patent |
2018-01-10
|
| (46) |
Date of publication of the claims translation |
2018-02-26
|
PCT application
| (86) |
Number |
PCT/US2015/036757 |
|
Date |
2015-06-19 |
PCT application publication
| (87) |
Number |
WO 2015/196116 |
|
Date |
2015-12-23 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201462015245 P |
2014-06-20
|
US |
Inventors
| (72) |
CARRA, Ernest, A., US
CHEN, Irene, US
ZIA, Vahid, US
|
Grantee
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Natrio (2R,5S,13aR) -7,9-diokso-10-((2,4,6-trifluorbenzil) karbamoil) -2,3,4,5,7,9,13,13A-oktahidro-2,5-metanopirido [1',2' : 4,5]pirazino[2,1-b]oksazepin-8-olatas |
| |
SODIUM (2R, 5S, 13AR) -7, 9-DIOXO-10- ( (2,4,6-TRIFLUOROBENZYL) CARBAMOYL) -2, 3, 4, 5, 7, 9, 13, 13A-OCTAHYDRO-2, 5-METHANOPYRIDO [1`,2` : 4.5]PYRAZINO [2, 1-B]OXAZEPIN-8-OLATE |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2018-05-31 |
4 |
92.00
EUR
|
Legal status
|
Patent revoked (after opposition at EPO)
|
|
|
Invalidation date |
2019-03-21 |
